ADIL

Adial Pharmaceuticals, Inc

1.45 USD
+0.25 (+20.83%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Adial Pharmaceuticals, Inc stock is down -14.71% since 30 days ago. The next earnings date is Jun 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 5 May’s closed higher than April.

About Adial Pharmaceuticals, Inc

Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction.